Monovisc (High-molecular-weight, lightly cross-linked sodium hyaluronate 88 mg / 4 ml) by Anika Therapeutics.
Indications: Symptomatic osteoarthritis of the knee (and other synovial joints per market) — single-injection viscosupplementation.
Administration: Single intra-articular injection by a physician.
Storage: Store at 2–25 °C. Do not freeze.
Medical device for use by licensed physicians only.
| Manufacturer | Anika Therapeutics |
| Active ingredient | High-molecular-weight, lightly cross-linked sodium hyaluronate 88 mg / 4 ml (22 mg/ml), non-animal origin. |
| Strength & pack | 1 pre-filled syringe of 4 ml. |
| Form | Intra-articular viscoelastic injection (medical device) |
| Storage | Store at 2–25 °C. Do not freeze. |
| Regulatory status | Medical device for use by licensed physicians only. |